In addition, only 8% of DLBCL cases exhibit structural variations disrupting the 3′-UTR of the PD-L1 gene that lead to the stabilization and elevation of aberrant PD-L1 transcripts [99]. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.